Intermittent supplementation with <i>Akkermansia muciniphila</i> and galactooligosaccharides modulates Alzheimer's disease progression, gut microbiota, and colon short-chain fatty acid profiles in mice.

Front Aging Neurosci · 2025 · PMC12256538 · PMID 40662084

Europe PMC DOI

hedged sentence

0.0581

closest p · 1.2× alpha

0.0581

boldest claim

The sentences

showed a trendp = 0.0581so close (0.05 < p ≤ 0.1)

muciniphila and GOS showed a trend ( p = 0.0581) towards fewer buried marbles, suggesting less impulsive or anxiety-induced behavior.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Intermittent supplementation with &lt;i&gt;Akkermansia muciniphila&lt;/i&gt; and galactooligosaccharides modulates Alzheimer's disease progression, gut microbiota, and colon short-chain fatty acid profiles in mice.

The sentences

Intermittent supplementation with <i>Akkermansia muciniphila</i> and galactooligosaccharides modulates Alzheimer's disease progression, gut microbiota, and colon short-chain fatty acid profiles in mice.